Lingjun Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lingjun Zheng has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Lizhu Zhang
Department of Food Science and Engineering, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, China
5 shared publicationsYaoyong Zeng
Shanghai Jiao Tong University
5 shared publicationsLongnong You
Shanghai Jiao Tong University
4 shared publications- Chao Zhao
College of Marine Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China
3 shared publications Haiyang Yu
Department of Food Science and Engineering, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, China
3 shared publicationsBingkuan Xu
Nanjing Normal University
2 shared publications
Latest Publications
- 10 November 2026
- Published by American Chemical Society (ACS) in Organic Letters
De Novo Access to Persubstituted Benzene-Fused Benzosilacyclohexanes via Organocatalytic Benzannulation of 4-Dicyanomethylene-1,1-Disubstituted Silacyclohexanes
We report an organocatalytic domino benzannulation strategy for the facile synthesis of persubstituted benzene-containing quinoline-fused silacyclohexanes and sila-tetrahydronaphthalenes using 4-dicyanomethylene-1,1-disubstituted silacyclohexanes as silicon-containing building blocks. The utility of this methodology was further demonstrated by a gram-scale synthesis, diverse transformations, and the promising antiproliferative activity against HCT-116 cells, along with the ability to modulate lysosome-associated pathways and mitigate the level of proteotoxic aggregation. This work provides a modular route to previously inaccessible persubstituted benzene-fused silacyclohexanes, offering new opportunities for silicon-containing functional molecules in drug discovery and materials science.
- 10 November 2026
- Published by American Chemical Society (ACS) in Organic Letters
De Novo Access to Persubstituted Benzene-Fused Benzosilacyclohexanes via Organocatalytic Benzannulation of 4-Dicyanomethylene-1,1-Disubstituted Silacyclohexanes
We report an organocatalytic domino benzannulation strategy for the facile synthesis of persubstituted benzene-containing quinoline-fused silacyclohexanes and sila-tetrahydronaphthalenes using 4-dicyanomethylene-1,1-disubstituted silacyclohexanes as silicon-containing building blocks. The utility of this methodology was further demonstrated by a gram-scale synthesis, diverse transformations, and the promising antiproliferative activity against HCT-116 cells, along with the ability to modulate lysosome-associated pathways and mitigate the level of proteotoxic aggregation. This work provides a modular route to previously inaccessible persubstituted benzene-fused silacyclohexanes, offering new opportunities for silicon-containing functional molecules in drug discovery and materials science.
- Open Access
- 23 October 2026
- Published by Springer Nature in Nature Communications
Tyramine mediates radiation-induced bystander effects
Radiation-induced bystander effects (RIBEs) compromise radioprotection and radiotherapy by propagating damage to non-irradiated cells; however, the mediators and underlying circuitry remain incompletely defined. Using localised UV irradiation as the primary experimental system and localised X-ray irradiation as a supportive test in an in vivo Caenorhabditis elegans model, we identify tyramine, a trace amine structurally and functionally related to adrenaline/noradrenaline, as a neuron-derived mediator of RIBEs. Tyramine released from tyraminergic RIM neurons activates TYRA-3, a tyramine-responsive adrenergic-like GPCR related to vertebrate adrenergic receptors. This neuron-to-intestine signal promotes secretion of the insulin-like peptide INS-5, aberrantly engages the DAF-2/insulin signalling pathway (IIS), and triggers endoplasmic reticulum stress, DNA damage responses, and embryonic lethality in non-irradiated tissues. These findings reveal a neuro–intestinal–germline axis that orchestrates RIBEs and uncover an unanticipated role for adrenaline-like signalling. Our work provides a conceptual framework for systematically discovering additional RIBE mediators and identifies pathway components for future evaluation as radioprotective or radiotherapy-modifying targets.
- 23 October 2026
- Published by Springer Nature in Nature Communications
Open AccessTyramine mediates radiation-induced bystander effects
Radiation-induced bystander effects (RIBEs) compromise radioprotection and radiotherapy by propagating damage to non-irradiated cells; however, the mediators and underlying circuitry remain incompletely defined. Using localised UV irradiation as the primary experimental system and localised X-ray irradiation as a supportive test in an in vivo Caenorhabditis elegans model, we identify tyramine, a trace amine structurally and functionally related to adrenaline/noradrenaline, as a neuron-derived mediator of RIBEs. Tyramine released from tyraminergic RIM neurons activates TYRA-3, a tyramine-responsive adrenergic-like GPCR related to vertebrate adrenergic receptors. This neuron-to-intestine signal promotes secretion of the insulin-like peptide INS-5, aberrantly engages the DAF-2/insulin signalling pathway (IIS), and triggers endoplasmic reticulum stress, DNA damage responses, and embryonic lethality in non-irradiated tissues. These findings reveal a neuro–intestinal–germline axis that orchestrates RIBEs and uncover an unanticipated role for adrenaline-like signalling. Our work provides a conceptual framework for systematically discovering additional RIBE mediators and identifies pathway components for future evaluation as radioprotective or radiotherapy-modifying targets.
- Open Access
- 10 October 2026
- Published by Wiley in Aging Cell
- Vol. 25 (10) , e70755
Ginsenoside Rg3 Promotes Healthy Aging Through Phosphoinositide‐Associated Lysosomal Regulation in Caenorhabditis elegans
Lysosomal decline and proteostasis collapse are defining features of aging and major contributors to neurodegenerative vulnerability, yet interventions that preserve neuronal lysosomal function across aging remain poorly defined. Here, we identify 20(S)‐ginsenoside Rg3, a ginseng‐derived natural product, as a geroprotective small molecule in Caenorhabditis elegans . Rg3 extended lifespan and preserved key physiological outputs, including locomotion and pharyngeal pumping, indicating that Rg3 delays functional aging. Rg3 also maintained mechanosensory neuron integrity and touch sensitivity, suppressed neuronal polyglutamine aggregation, and protected dopaminergic neurons against α‐synuclein‐induced degeneration. At the cellular level, Rg3 restored age‐impaired lysosomal function and autophagic flux in neurons. Mechanistically, Rg3 shifted neuronal phosphoinositide reporter signatures toward a PI(4)P‐enriched and PI(3)P‐reduced state, consistent with signaling lipid remodeling at lysosomal membranes. This phosphoinositide shift coincided with reduced RSKS‐1/S6K phosphorylation, indicating suppression of TOR complex 1 (TORC1), and promoted nuclear localization of HLH‐30, the C. elegans ortholog of transcription factor EB (TFEB), thereby engaging a conserved lysosomal program. Collectively, these results define Rg3 as a natural‐product geroprotector that couples lysosomal lipid remodeling to TORC1–HLH‐30 signaling to preserve lysosomal competence, neuronal proteostasis, and organismal fitness during aging. Our study nominates phosphoinositide control of lysosomal identity as a therapeutic entry point for healthy aging and neuroprotection.
- 10 October 2026
- Published by Wiley in Aging Cell
- Vol. 25 (10) , e70755
Open AccessGinsenoside Rg3 Promotes Healthy Aging Through Phosphoinositide‐Associated Lysosomal Regulation in Caenorhabditis elegans
Lysosomal decline and proteostasis collapse are defining features of aging and major contributors to neurodegenerative vulnerability, yet interventions that preserve neuronal lysosomal function across aging remain poorly defined. Here, we identify 20(S)‐ginsenoside Rg3, a ginseng‐derived natural product, as a geroprotective small molecule in Caenorhabditis elegans . Rg3 extended lifespan and preserved key physiological outputs, including locomotion and pharyngeal pumping, indicating that Rg3 delays functional aging. Rg3 also maintained mechanosensory neuron integrity and touch sensitivity, suppressed neuronal polyglutamine aggregation, and protected dopaminergic neurons against α‐synuclein‐induced degeneration. At the cellular level, Rg3 restored age‐impaired lysosomal function and autophagic flux in neurons. Mechanistically, Rg3 shifted neuronal phosphoinositide reporter signatures toward a PI(4)P‐enriched and PI(3)P‐reduced state, consistent with signaling lipid remodeling at lysosomal membranes. This phosphoinositide shift coincided with reduced RSKS‐1/S6K phosphorylation, indicating suppression of TOR complex 1 (TORC1), and promoted nuclear localization of HLH‐30, the C. elegans ortholog of transcription factor EB (TFEB), thereby engaging a conserved lysosomal program. Collectively, these results define Rg3 as a natural‐product geroprotector that couples lysosomal lipid remodeling to TORC1–HLH‐30 signaling to preserve lysosomal competence, neuronal proteostasis, and organismal fitness during aging. Our study nominates phosphoinositide control of lysosomal identity as a therapeutic entry point for healthy aging and neuroprotection.
- 28 August 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (41) , 44505-44519
Enantioselective Decarboxylative Synthesis of Chiral α-Silylamines and α-Germylamines
Metalloids bridge the properties of metals and nonmetals, creating unique opportunities in drug discovery. However, the potential of silicon- and germanium-containing scaffolds in organic synthesis and medicinal chemistry remain underexplored, largely owing to the lack of general stereocontrolled synthetic methods, particularly for value-added chiral α-silylamines and α-germylamines. Here, we report a robust nickel-catalyzed enantioselective decarboxylative cross-coupling of amino acid or peptide-derived redox-active esters with silylzinc and germylzinc reagents. The method exhibits a broad substrate scope and delivers excellent performance under mild conditions. Its efficacy is further demonstrated through the late-stage diversification of complex bioactive peptides, and both enantiomers can be accessed with high stereochemical fidelity. Mechanistic investigations delineate the origin of stereocontrol, while preliminary biological evaluations show promising activities, with Ge substitution in several cases surpassing Si and certain clinically marketed boron-containing drugs. Collectively, this work establishes an efficient and enantioselective route to chiral α-silylamines and α-germylamines, underscoring their potential to expand peptide chemical space and to enable the development of peptide-based therapeutics and diagnostics.
- 28 August 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (41) , 44505-44519
Enantioselective Decarboxylative Synthesis of Chiral α-Silylamines and α-Germylamines
Metalloids bridge the properties of metals and nonmetals, creating unique opportunities in drug discovery. However, the potential of silicon- and germanium-containing scaffolds in organic synthesis and medicinal chemistry remain underexplored, largely owing to the lack of general stereocontrolled synthetic methods, particularly for value-added chiral α-silylamines and α-germylamines. Here, we report a robust nickel-catalyzed enantioselective decarboxylative cross-coupling of amino acid or peptide-derived redox-active esters with silylzinc and germylzinc reagents. The method exhibits a broad substrate scope and delivers excellent performance under mild conditions. Its efficacy is further demonstrated through the late-stage diversification of complex bioactive peptides, and both enantiomers can be accessed with high stereochemical fidelity. Mechanistic investigations delineate the origin of stereocontrol, while preliminary biological evaluations show promising activities, with Ge substitution in several cases surpassing Si and certain clinically marketed boron-containing drugs. Collectively, this work establishes an efficient and enantioselective route to chiral α-silylamines and α-germylamines, underscoring their potential to expand peptide chemical space and to enable the development of peptide-based therapeutics and diagnostics.
- 13 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (33) , 26389-26400
Identification of Cysl-2 as a Compensatory Factor in Vitamin B12-Mediated Protection in a Mitochondrial Aβ Toxicity Model
Alzheimer’s disease (AD) is a highly sophisticated disease associated with mitochondrial deterioration, which potentiates proteotoxic stress and accelerates neuronal decline. Vitamin B12 (B12), an essential cofactor in one-carbon metabolism and cellular homeostasis, plays a pivotal role in modulating neurodegenerative pathology. Here, we established a mitochondrial-associated AD model by using Caenorhabditis elegans (C. elegans) expressing Aβ combining with the mtDNA deletion uaDf5, and evaluated the effect of B12 as a metabolic modulator of neurodegenerative stress. We observed that mitochondrial dysfunction markedly exacerbated Aβ phenotypes, while B12 mitigated paralysis and cellular deficits. Integrated transcriptomics and proteomics revealed a compensatory mechanism activated by B12 under mitochondrial stress, predominantly engaging one-carbon and transsulfuration pathways. Functional analyses uncovered that metr-1 and cysl-2 are required for B12-mediated protection, and multiomics corroborated this rescue axis. This study indicates that cysl-2 is an essential mediator and reveals a B12-driven adaptive response, which provides mechanistic insight into nutrition-based neuroprotection in AD.
- 13 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (33) , 26389-26400
Identification of Cysl-2 as a Compensatory Factor in Vitamin B12-Mediated Protection in a Mitochondrial Aβ Toxicity Model
Alzheimer’s disease (AD) is a highly sophisticated disease associated with mitochondrial deterioration, which potentiates proteotoxic stress and accelerates neuronal decline. Vitamin B12 (B12), an essential cofactor in one-carbon metabolism and cellular homeostasis, plays a pivotal role in modulating neurodegenerative pathology. Here, we established a mitochondrial-associated AD model by using Caenorhabditis elegans (C. elegans) expressing Aβ combining with the mtDNA deletion uaDf5, and evaluated the effect of B12 as a metabolic modulator of neurodegenerative stress. We observed that mitochondrial dysfunction markedly exacerbated Aβ phenotypes, while B12 mitigated paralysis and cellular deficits. Integrated transcriptomics and proteomics revealed a compensatory mechanism activated by B12 under mitochondrial stress, predominantly engaging one-carbon and transsulfuration pathways. Functional analyses uncovered that metr-1 and cysl-2 are required for B12-mediated protection, and multiomics corroborated this rescue axis. This study indicates that cysl-2 is an essential mediator and reveals a B12-driven adaptive response, which provides mechanistic insight into nutrition-based neuroprotection in AD.
- 13 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (33) , 26183-26195
Targeting of α-Syn Condensate Fluidity by Natural Polyphenols to Retard the Amyloid Transition and Ameliorate α-Syn-Caused Neurotoxicity
The key pathology of Parkinson’s disease (PD) is the presence of Lewy bodies, which contain aggregated α-synuclein (α-Syn). Recent studies revealed that liquid–liquid phase separation (LLPS) is critical for α-Syn aggregation. This study investigates the regulatory effects of three food-related natural polyphenols on α-Syn LLPS and amyloid transition. We discovered that, rather than epigallocatechin gallate (EGCG) and gallic acid (GA), tannic acid (TA) dynamically regulates α-Syn LLPS by increasing α-Syn mobility within the condensates. TA promotes α-Syn condensate fusion but retards the liquid-to-solid phase transition, inhibiting α-Syn aggregation. Further studies showed that TA strongly blocks α-Syn seed-induced aggregation in neuronal cells and exerts neuroprotective effects against α-Syn in Caenorhabditis elegans. Our findings demonstrate that the regulation of LLPS-driven α-Syn amyloid aggregation by small molecules differs from that of nucleation-dependent deposition, providing new insights into targeting α-Syn phase separation in the treatment of PD and other protein aggregation-related diseases.
- 13 August 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (33) , 26183-26195
Targeting of α-Syn Condensate Fluidity by Natural Polyphenols to Retard the Amyloid Transition and Ameliorate α-Syn-Caused Neurotoxicity
The key pathology of Parkinson’s disease (PD) is the presence of Lewy bodies, which contain aggregated α-synuclein (α-Syn). Recent studies revealed that liquid–liquid phase separation (LLPS) is critical for α-Syn aggregation. This study investigates the regulatory effects of three food-related natural polyphenols on α-Syn LLPS and amyloid transition. We discovered that, rather than epigallocatechin gallate (EGCG) and gallic acid (GA), tannic acid (TA) dynamically regulates α-Syn LLPS by increasing α-Syn mobility within the condensates. TA promotes α-Syn condensate fusion but retards the liquid-to-solid phase transition, inhibiting α-Syn aggregation. Further studies showed that TA strongly blocks α-Syn seed-induced aggregation in neuronal cells and exerts neuroprotective effects against α-Syn in Caenorhabditis elegans. Our findings demonstrate that the regulation of LLPS-driven α-Syn amyloid aggregation by small molecules differs from that of nucleation-dependent deposition, providing new insights into targeting α-Syn phase separation in the treatment of PD and other protein aggregation-related diseases.
- 18 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (25) , 25788-25802
Stereoretentive and Regioselective Late-Stage C–H Glycosylation
Glycosylation of drug molecules offers an effective strategy to modulate pharmacological properties, and late-stage C-H glycosylation represents an appealing yet challenging strategy for direct molecular diversification. Current chemical and enzymatic methods often exhibit strong substrate dependence and limited control over site- and stereoselectivity, restricting their general applicability. Here, we describe a general platform that integrates highly site-selective aromatic C-H thianthrenation with stereoretentive palladium-catalyzed glycosyl cross-coupling, enabling access to both α- and β-C-glycosylated drug derivatives, including direct coupling with fully unprotected sugars. By exploiting complementary direct C-H and C-B thianthrenation pathways, this strategy enables regiodivergent synthesis of a broad range of C-glycosylated drug analogs. Within the context of organothianthrenium chemistry, this work establishes a stereospecific C(sp3)-C(sp2) cross-coupling mode for glycosyl nucleophile. In vivo studies in Caenorhabditis elegans reveal that C-glycosylation of small-molecule drugs can substantially modulate antitumor efficacy and neuroprotection. Moreover, glycosyl stannanes are shown to exhibit intrinsic antitumor activity and therapeutic potential in Huntington's disease models. Collectively, this late-stage C-H glycosylation platform provides a general and precise strategy for drug glycodiversification, accelerating sugar-based drug discovery and expanding the toolbox for late-stage functionalization of pharmaceutical molecules.
- 18 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (25) , 25788-25802
Stereoretentive and Regioselective Late-Stage C–H Glycosylation
Glycosylation of drug molecules offers an effective strategy to modulate pharmacological properties, and late-stage C-H glycosylation represents an appealing yet challenging strategy for direct molecular diversification. Current chemical and enzymatic methods often exhibit strong substrate dependence and limited control over site- and stereoselectivity, restricting their general applicability. Here, we describe a general platform that integrates highly site-selective aromatic C-H thianthrenation with stereoretentive palladium-catalyzed glycosyl cross-coupling, enabling access to both α- and β-C-glycosylated drug derivatives, including direct coupling with fully unprotected sugars. By exploiting complementary direct C-H and C-B thianthrenation pathways, this strategy enables regiodivergent synthesis of a broad range of C-glycosylated drug analogs. Within the context of organothianthrenium chemistry, this work establishes a stereospecific C(sp3)-C(sp2) cross-coupling mode for glycosyl nucleophile. In vivo studies in Caenorhabditis elegans reveal that C-glycosylation of small-molecule drugs can substantially modulate antitumor efficacy and neuroprotection. Moreover, glycosyl stannanes are shown to exhibit intrinsic antitumor activity and therapeutic potential in Huntington's disease models. Collectively, this late-stage C-H glycosylation platform provides a general and precise strategy for drug glycodiversification, accelerating sugar-based drug discovery and expanding the toolbox for late-stage functionalization of pharmaceutical molecules.
- 17 June 2026
- Published by Elsevier in Phytomedicine
- Vol. 159, 158448
Piperine inhibits NLRP3 inflammasome activation and alleviates inflammatory disease
- 17 June 2026
- Published by Elsevier in Phytomedicine
- Vol. 159, 158448
Piperine inhibits NLRP3 inflammasome activation and alleviates inflammatory disease
- 22 July 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (31) , 19631-19641
The Key Flavor Substance in Zanthoxylum Preventing Alzheimer’s Disease through Insulin Signaling
Alzheimer's disease (AD), affecting over 50 million people globally, is a leading cause of dementia with severe socioeconomic impacts. A key pathological feature is β-amyloid (Aβ) aggregation, driving neurodegeneration. This study investigates WGX-50, a bioactive amide from Zanthoxylum bungeanum, for its anti-AD potential using Caenorhabditis elegans models (CL2355/GMC101). WGX-50 reduced Aβ deposition in neuronal and muscle tissues while improving mobility, reproductive fitness, and cognitive functions. Mechanistically, transcriptomics revealed WGX-50's modulation of immune-related genes, validated by RNAi and RT-qPCR, suggesting the involvement of the insulin signaling (IIS) pathway in Aβ suppression. Our findings highlight WGX-50's dual therapeutic and prophylactic effects against Aβ toxicity, highlighting it as a promising neuroprotective agent. The study not only elucidates WGX-50's mode of action but also advances Z. bungeanum-derived flavor compounds as functional food candidates for neurodegenerative disease prevention, offering novel strategies for AD intervention.
- 22 July 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (31) , 19631-19641
The Key Flavor Substance in Zanthoxylum Preventing Alzheimer’s Disease through Insulin Signaling
Alzheimer's disease (AD), affecting over 50 million people globally, is a leading cause of dementia with severe socioeconomic impacts. A key pathological feature is β-amyloid (Aβ) aggregation, driving neurodegeneration. This study investigates WGX-50, a bioactive amide from Zanthoxylum bungeanum, for its anti-AD potential using Caenorhabditis elegans models (CL2355/GMC101). WGX-50 reduced Aβ deposition in neuronal and muscle tissues while improving mobility, reproductive fitness, and cognitive functions. Mechanistically, transcriptomics revealed WGX-50's modulation of immune-related genes, validated by RNAi and RT-qPCR, suggesting the involvement of the insulin signaling (IIS) pathway in Aβ suppression. Our findings highlight WGX-50's dual therapeutic and prophylactic effects against Aβ toxicity, highlighting it as a promising neuroprotective agent. The study not only elucidates WGX-50's mode of action but also advances Z. bungeanum-derived flavor compounds as functional food candidates for neurodegenerative disease prevention, offering novel strategies for AD intervention.
- Open Access
- 28 May 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (6) , 115761
β-synuclein blocks α-synuclein condensate fusion to disrupt the maturation of phase separation
- 28 May 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (6) , 115761
Open Accessβ-synuclein blocks α-synuclein condensate fusion to disrupt the maturation of phase separation